Activation of mGluR1, PKC and map kinase pathway is required for post-ischemic LTP in the striatum

Research output: Contribution to journalArticle

Abstract

Excessive activation of glutamate receptors is widely accepted as one of the most important determinants in the development of tissue damage produced by both cerebral ischemia and neurodegenerative disorders. However, how energy deprivation predisposes to excitotoxic insults is still largely unclear. To address this crucial issue, intracellular and whole-cell patch clamp recordings were performed from both striatal GABAergic projection neurons and cholinergic interneurons in a rat corticolstriatal slice preparation. Interestingly, striatal GABAergic-projecting cells are highly vulnerable in the course of both brain ischemia and Huntington's disease, whereas striatal cholinergic interneurons tend to be spared by these insults, presumably reflecting differential sensitivity to excitotoxic processes triggered by metabolic impairment. Accordingly, we found that brief periods (3-4 min) of combined oxygen and glucose deprivation causes in striatal projection neurons but not cholinergic interneurons a dramatic and irreversible increase in neuronal sensitivity to synaptically released glutamate (post-ischemic long-term potentiation, i-LTP). This pathological form of synaptic plasticity is dependent on the stimulation of NMDA glutamate receptors but involves both NMDA and AMPA-mediated synaptic transmission. Stimulation of metabotropic glutamate receptors 1 (mGluRsl) is a critical requirement for the induction of i-LTP since it is fully prevented by selective antagonists of this receptor subtype and is absent in mice lacking mGluRsl. Intracellular application of either calcium chelating agents of protein kinase C (PKC) inhibitors blocks the induction of i-LTP, indicating that calcium elevation and PKC activation represent the post-receptor events leading to this pathological form of synaptic plasticity. Finally, the pharmacological inhibition of mitogen-activated protein (MAP) kinase ERK also prevents i-LTP, supporting the conclusion that ischemia- and glutamate-activated intracellular events converge on this downstream cellular effector to i-LTP. It is proposed that this synaptic phenomenon might be responsible for delayed neuronal death in several pathological conditions and that its pharmacological modulation might constitute an alternative approach to the therapy of both acute and chronic neurological disorders.

Original languageEnglish
JournalNeurological Sciences
Volume21
Issue number4 SUPPL.
Publication statusPublished - 2000

Fingerprint

Long-Term Potentiation
Mitogen-Activated Protein Kinase Kinases
Corpus Striatum
Interneurons
Neuronal Plasticity
Glutamate Receptors
Brain Ischemia
Protein Kinase C
Cholinergic Agents
Glutamic Acid
Pharmacology
GABAergic Neurons
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
Cholinergic Neurons
Protein C Inhibitor
Huntington Disease
Brain Diseases
N-Methylaspartate
Protein Kinase Inhibitors
Mitogen-Activated Protein Kinases

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Activation of mGluR1, PKC and map kinase pathway is required for post-ischemic LTP in the striatum. / Calabresi, P.

In: Neurological Sciences, Vol. 21, No. 4 SUPPL., 2000.

Research output: Contribution to journalArticle

@article{1ea4eca0d8684bd789b2decf8e3e2793,
title = "Activation of mGluR1, PKC and map kinase pathway is required for post-ischemic LTP in the striatum",
abstract = "Excessive activation of glutamate receptors is widely accepted as one of the most important determinants in the development of tissue damage produced by both cerebral ischemia and neurodegenerative disorders. However, how energy deprivation predisposes to excitotoxic insults is still largely unclear. To address this crucial issue, intracellular and whole-cell patch clamp recordings were performed from both striatal GABAergic projection neurons and cholinergic interneurons in a rat corticolstriatal slice preparation. Interestingly, striatal GABAergic-projecting cells are highly vulnerable in the course of both brain ischemia and Huntington's disease, whereas striatal cholinergic interneurons tend to be spared by these insults, presumably reflecting differential sensitivity to excitotoxic processes triggered by metabolic impairment. Accordingly, we found that brief periods (3-4 min) of combined oxygen and glucose deprivation causes in striatal projection neurons but not cholinergic interneurons a dramatic and irreversible increase in neuronal sensitivity to synaptically released glutamate (post-ischemic long-term potentiation, i-LTP). This pathological form of synaptic plasticity is dependent on the stimulation of NMDA glutamate receptors but involves both NMDA and AMPA-mediated synaptic transmission. Stimulation of metabotropic glutamate receptors 1 (mGluRsl) is a critical requirement for the induction of i-LTP since it is fully prevented by selective antagonists of this receptor subtype and is absent in mice lacking mGluRsl. Intracellular application of either calcium chelating agents of protein kinase C (PKC) inhibitors blocks the induction of i-LTP, indicating that calcium elevation and PKC activation represent the post-receptor events leading to this pathological form of synaptic plasticity. Finally, the pharmacological inhibition of mitogen-activated protein (MAP) kinase ERK also prevents i-LTP, supporting the conclusion that ischemia- and glutamate-activated intracellular events converge on this downstream cellular effector to i-LTP. It is proposed that this synaptic phenomenon might be responsible for delayed neuronal death in several pathological conditions and that its pharmacological modulation might constitute an alternative approach to the therapy of both acute and chronic neurological disorders.",
author = "P. Calabresi",
year = "2000",
language = "English",
volume = "21",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Activation of mGluR1, PKC and map kinase pathway is required for post-ischemic LTP in the striatum

AU - Calabresi, P.

PY - 2000

Y1 - 2000

N2 - Excessive activation of glutamate receptors is widely accepted as one of the most important determinants in the development of tissue damage produced by both cerebral ischemia and neurodegenerative disorders. However, how energy deprivation predisposes to excitotoxic insults is still largely unclear. To address this crucial issue, intracellular and whole-cell patch clamp recordings were performed from both striatal GABAergic projection neurons and cholinergic interneurons in a rat corticolstriatal slice preparation. Interestingly, striatal GABAergic-projecting cells are highly vulnerable in the course of both brain ischemia and Huntington's disease, whereas striatal cholinergic interneurons tend to be spared by these insults, presumably reflecting differential sensitivity to excitotoxic processes triggered by metabolic impairment. Accordingly, we found that brief periods (3-4 min) of combined oxygen and glucose deprivation causes in striatal projection neurons but not cholinergic interneurons a dramatic and irreversible increase in neuronal sensitivity to synaptically released glutamate (post-ischemic long-term potentiation, i-LTP). This pathological form of synaptic plasticity is dependent on the stimulation of NMDA glutamate receptors but involves both NMDA and AMPA-mediated synaptic transmission. Stimulation of metabotropic glutamate receptors 1 (mGluRsl) is a critical requirement for the induction of i-LTP since it is fully prevented by selective antagonists of this receptor subtype and is absent in mice lacking mGluRsl. Intracellular application of either calcium chelating agents of protein kinase C (PKC) inhibitors blocks the induction of i-LTP, indicating that calcium elevation and PKC activation represent the post-receptor events leading to this pathological form of synaptic plasticity. Finally, the pharmacological inhibition of mitogen-activated protein (MAP) kinase ERK also prevents i-LTP, supporting the conclusion that ischemia- and glutamate-activated intracellular events converge on this downstream cellular effector to i-LTP. It is proposed that this synaptic phenomenon might be responsible for delayed neuronal death in several pathological conditions and that its pharmacological modulation might constitute an alternative approach to the therapy of both acute and chronic neurological disorders.

AB - Excessive activation of glutamate receptors is widely accepted as one of the most important determinants in the development of tissue damage produced by both cerebral ischemia and neurodegenerative disorders. However, how energy deprivation predisposes to excitotoxic insults is still largely unclear. To address this crucial issue, intracellular and whole-cell patch clamp recordings were performed from both striatal GABAergic projection neurons and cholinergic interneurons in a rat corticolstriatal slice preparation. Interestingly, striatal GABAergic-projecting cells are highly vulnerable in the course of both brain ischemia and Huntington's disease, whereas striatal cholinergic interneurons tend to be spared by these insults, presumably reflecting differential sensitivity to excitotoxic processes triggered by metabolic impairment. Accordingly, we found that brief periods (3-4 min) of combined oxygen and glucose deprivation causes in striatal projection neurons but not cholinergic interneurons a dramatic and irreversible increase in neuronal sensitivity to synaptically released glutamate (post-ischemic long-term potentiation, i-LTP). This pathological form of synaptic plasticity is dependent on the stimulation of NMDA glutamate receptors but involves both NMDA and AMPA-mediated synaptic transmission. Stimulation of metabotropic glutamate receptors 1 (mGluRsl) is a critical requirement for the induction of i-LTP since it is fully prevented by selective antagonists of this receptor subtype and is absent in mice lacking mGluRsl. Intracellular application of either calcium chelating agents of protein kinase C (PKC) inhibitors blocks the induction of i-LTP, indicating that calcium elevation and PKC activation represent the post-receptor events leading to this pathological form of synaptic plasticity. Finally, the pharmacological inhibition of mitogen-activated protein (MAP) kinase ERK also prevents i-LTP, supporting the conclusion that ischemia- and glutamate-activated intracellular events converge on this downstream cellular effector to i-LTP. It is proposed that this synaptic phenomenon might be responsible for delayed neuronal death in several pathological conditions and that its pharmacological modulation might constitute an alternative approach to the therapy of both acute and chronic neurological disorders.

UR - http://www.scopus.com/inward/record.url?scp=33845342240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845342240&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33845342240

VL - 21

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 4 SUPPL.

ER -